Inflammatory Biomarker Levels Among Patients With HIV Infection Similar Between Those Who Switch To DTG/3TC And Those Who Remain On TAF-Based Antiretroviral Regimens, Study Finds

Infectious Disease Advisor (1/8, Nye) reports, “Results of a study ... suggest that inflammatory biomarker levels among patients with HIV infection are similar between those who switch to dolutegravir plus lamivudine and those who remain on tenofovir alafenamide-based antiretroviral regimens.” The findings were published in Open Forum Infectious Diseases.